TLCD1 and cancer: We further investigated the association between TLCD1 expression and 60 immune checkpoint pathway genes, divided into two classes (inhibitory and stimulatory) (Thorsson et al., 2018), using Spearman correlation analysis across the pan-cancer data (Figure 6A).